Baldwin DS - Search Results

1

Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.

Nutt DJ, Baldwin DS, Clayton AH, Elgie R, Lecrubier Y, Montejo AL, Papakostas GI, Souery D, Trivedi MH, Tylee A. Nutt DJ, et al. Among authors: baldwin ds. J Clin Psychiatry. 2006;67 Suppl 6:46-9. J Clin Psychiatry. 2006. PMID: 16848678

2

Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety.

Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Baldwin DS, den Boer JA, Kasper S, Shear MK. Ballenger JC, et al. Among authors: baldwin ds. J Clin Psychiatry. 1998;59 Suppl 8:47-54. J Clin Psychiatry. 1998. PMID: 9707162 Review.

3

Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Möller HJ, Baldwin DS, Goodwin G, Kasper S, Okasha A, Stein DJ, Tandon R, Versiani M; WPA Section on Pharmacopsychiatry. Möller HJ, et al. Among authors: baldwin ds. Eur Arch Psychiatry Clin Neurosci. 2008 Aug;258 Suppl 3:3-23. doi: 10.1007/s00406-008-3002-1. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 18668279 Review.

4

The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.

Montejo AL, Montejo L, Baldwin DS. Montejo AL, et al. Among authors: baldwin ds. World Psychiatry. 2018 Feb;17(1):3-11. doi: 10.1002/wps.20509. World Psychiatry. 2018. PMID: 29352532 Free PMC article.

5

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG. Wilson SJ, et al. Among authors: baldwin ds. J Psychopharmacol. 2010 Nov;24(11):1577-601. doi: 10.1177/0269881110379307. Epub 2010 Sep 2. J Psychopharmacol. 2010. PMID: 20813762 Review.

6

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.

Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU; British Association for Psychopharmacology. Baldwin DS, et al. J Psychopharmacol. 2005 Nov;19(6):567-96. doi: 10.1177/0269881105059253. J Psychopharmacol. 2005. PMID: 16272179

7

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, Mikova O, Nutt D, Pallanti S, Pini S, Ströhle A, Thibaut F, Vaghi MM, Won E, Wedekind D, Wichniak A, Woolley J, Zwanzger P, Riederer P. Bandelow B, et al. World J Biol Psychiatry. 2017 Apr;18(3):162-214. doi: 10.1080/15622975.2016.1190867. Epub 2016 Jul 15. World J Biol Psychiatry. 2017. PMID: 27419272 Free PMC article. Review.

8

A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.

Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A. Baldwin DS, et al. J Clin Psychiatry. 1996;57 Suppl 2:46-52. J Clin Psychiatry. 1996. PMID: 8626363 Clinical Trial.

9

No psychiatry without psychopharmacology.

Harrison PJ, Baldwin DS, Barnes TR, Burns T, Ebmeier KP, Ferrieer IN, Nutt DJ. Harrison PJ, et al. Among authors: baldwin ds. Br J Psychiatry. 2011 Oct;199(4):263-5. doi: 10.1192/bjp.bp.111.094334. Br J Psychiatry. 2011. PMID: 22187725 No abstract available.

10

ECNP Consensus Meeting, March 2003. Guidelines for the investigation of efficacy in social anxiety disorder.

Montgomery SA, Lecrubier Y, Baldwin DS, Kasper S, Lader M, Nil R, Stein D, Van Ree JM; European College of Neuropsychopharmacology. Montgomery SA, et al. Among authors: baldwin ds. Eur Neuropsychopharmacol. 2004 Oct;14(5):425-33. doi: 10.1016/j.euroneuro.2004.06.001. Eur Neuropsychopharmacol. 2004. PMID: 15336305 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters